|
gptkbp:instanceOf
|
oral contraceptive
|
|
gptkbp:activeIngredient
|
gptkb:levonorgestrel
|
|
gptkbp:approvalYear
|
2000
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
gptkb:G02BA03
|
|
gptkbp:contraindication
|
current pelvic infection
known or suspected pregnancy
uterine abnormalities
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:effect
|
up to 8 years
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Mirena
|
|
gptkbp:manufacturer
|
gptkb:Bayer
|
|
gptkbp:mechanismOfAction
|
releases levonorgestrel to prevent pregnancy
|
|
gptkbp:notRecommendedFor
|
women with unexplained vaginal bleeding
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:removalRequired
|
yes
|
|
gptkbp:routeOfAdministration
|
intrauterine
|
|
gptkbp:sideEffect
|
gptkb:ovarian_cysts
abdominal pain
headache
breast tenderness
irregular bleeding
|
|
gptkbp:usedFor
|
birth control
treatment of heavy menstrual bleeding
|
|
gptkbp:website
|
https://www.mirena-us.com/
|
|
gptkbp:bfsParent
|
gptkb:Bayer
|
|
gptkbp:bfsLayer
|
5
|